Nasdaq

Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium

IRVINE, Calif., Feb. 2, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced 12-month results from the company ...
Orange County Business Journal

Biosense Webster Aims to Reduce Radiation Exposure

Webster has developed the Carto 3 mapping and navigation system that provides 3D imaging Irvine-based Biosense Webster, a unit of Johnson & Johnson, said it’s developed a way to help patients and ...
Nasdaq

Biosense Webster Receives FDA Approval for THERMOCOOL SMARTTOUCH® SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation

The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients* IRVINE, ...
FiercePharma

Biosense Webster Enrolls First Patient in Groundbreaking SMART-AF Trial

Completes First Atrial Fibrillation Ablation Case in the United States Using The THERMOCOOL ® SMARTTOUCH ™ Contact Force Sensing Catheter & Software Module DIAMOND BAR, Calif.--(BUSINESS WIRE)-- ...
FiercePharma

Biosense Webster Receives FDA Clearances for the CARTOXPRESS™ Software Module and LASSO® NAV Catheter for its CARTO®

State-of-the-Art Software and new sensor-enabled catheter provides Electrophysiologists with an unparalleled level of speed and visualization in their 3D Mapping and Ablation procedures. FAM is a ...
Seeking Alpha

Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias

Industry's highest density fixed array mapping catheter, covering the largest area in a fixed matrix format, can help physicians effectively map in a shorter procedure time "The OPTRELL™ Mapping ...
FierceBiotech

J&J's Biosense Webster puts forward pulsed field ablation data showing no afib after one year

Johnson & Johnson Medtech’s Biosense Webster division presented the final results from a yearlong study of its upcoming Varipulse pulsed field ablation system, showing that more than three-quarters of ...
Business Wire

Biosense Webster Successfully Completes First Clinical Atrial Fibrillation Ablation Cases in the European Union Using the THERMOCOOL ® SMARTTOUCH™ Contact Force Sensing Catheter

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a Johnson & Johnson company, and a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the successful ...
AOL

Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety an

Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL®SMARTTOUCH™Catheter THERMOCOOL® SMARTTOUCH™ Catheter and Software ...
Business Wire

Biosense Webster, Inc. Launches Outcomes-Based, Risk-Sharing Program to Reinforce Significant Patient Benefits Demonstrated by Company’s Leading Contact Force Therapy

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the launch of the BIOSENSE WEBSTER ADVANTAGE SM ...